Pragmatic approach needed to Ozempic compounding concerns

TGA should crack down on “rogue pharmacists” rather than rolling out a ban on compounding Ozempic (semaglutide), an obesity expert claims  Pragmatism is needed when it comes to regulating the compounding of Ozempic, Professor Gary Wittert from the University of Adelaide says.   The Therapeutic Goods Administration (TGA) is currently conducting a consultation to remove